The approval of new therapies increasingly relies on an ecosystem of strategic partnerships during various stages of the development pipeline. Successfully managing these partnerships has become a critical component to the underlying success of each partner and the biopharma industry. As the quantity and complexity of deals increase, alliance teams have rapidly evolved, developing innovative strategies, systematic approaches and best practices to maximize value, and to leverage strategic partnerships above and beyond the deal.
Cambridge Healthtech Institute’s 15th Annual Strategic Alliance Management Congress, May 7-9, brings together senior alliance management, business development, technology transfer and licensing professionals, to network, share experiences, discuss case studies, and to share the components that cultivate successful partnerships. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders advancing the art of alliance management.